Woodcock to Lead Planned Pharmaceutical Quality Office

Washington Drug Letter
CDER Director Janet Woodcock has decided to head the FDA’s new Office of Pharmaceutical Quality (OPQ) herself until it gets off the ground. The new office is planned as a “super office” that will oversee manufacturing quality throughout a drug’s lifecycle.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00